Angiotensin-converting enzyme inhibitors from Salvia elegans Vahl

Ana Silvia Gutiérrez-Román, Manasés Gonzalez-Cortazar, Gabriela Trejo-Tapia, Maribel Herrera-Ruiz, Alejandro Zamilpa, Ernesto Sanchéz-Mendoza, Natividad Giovana De la Cruz- Sanchez, Enrique Jiménez-Ferrer

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

2 Citas (Scopus)

Resumen

Phytochemical research of the acetate and methanol extracts of the aerial parts (flowers, leaves and stems) of Salvia elegans allowed to obtain seventeen known compounds (1–17): three of them (4, 5, 14), had already been described for this species, while the others (1–3, 6–13, 15–17) are described for the first time for S. elegans. All isolated compounds were characterized using spectroscopic techniques and mass spectrometry and were evaluated in the Angiotensin I-converting enzyme (ACE) inhibition model, where the phenolic compounds (13, 14 and 15) had the same inhibitory effect as lisinopril at 0.02 mg/mL. The terpenes showed a moderate inhibitory capacity at a concentration of 0.2 mg/mL.

Idioma originalInglés
Páginas (desde-hasta)5344-5349
Número de páginas6
PublicaciónNatural Product Research
Volumen35
N.º23
DOI
EstadoPublicada - 2021

Huella

Profundice en los temas de investigación de 'Angiotensin-converting enzyme inhibitors from Salvia elegans Vahl'. En conjunto forman una huella única.

Citar esto